CytomX Therapeutics (CTMX) Earnings
|
Expand Research on CTMX
| Next EPS Date | 11/10/26 | EPS Growth Rate | +22.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +6.0% | Revenue Growth Rate | +76.8% |
| Average % Move 1-Wk after EPS | -7.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/26  |
Q326 | N/A | -$0.07 | N/A | N/A | $10.43M | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | -$0.09 | -$0.08 | -$0.01 | $1.41M | $11.33M | N/A |  | | Details | |
| 5/7/26 |
Q126 | -$0.10 | -$0.12 | +$0.02 | $10.26M | $4.64M | N/A | | | Details | |
| 5/4/26 |
Q126 | N/A | -$0.12 | N/A | N/A | $4.64M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.12 | N/A | N/A | $4.64M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.12 | N/A | N/A | $4.64M | N/A | N/A | N/A | ||
| 3/16/26 |
Q425 | N/A | -$0.09 | N/A | N/A | $9.88M | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.09 | N/A | N/A | $9.88M | N/A | N/A | N/A |
